TY - JOUR
T1 - Critical role of miR-10b in B-Raf V600E dependent anchorage independent growth and invasion of melanoma cells
AU - Datar, Ila
AU - Kalpana, Gardiyawasam
AU - Choi, Jungmin
AU - Basuroy, Tupa
AU - Trumbly, Robert
AU - Arudra, Sri Krishna Chaitanya
AU - McPhee, Michael D.
AU - De La Serna, Ivana
AU - Yeung, Kam C.
N1 - Funding Information:
UT Foundation, a gift from Clement Lam to KCY, and a Translation Research Stimulation Award (TRSA) from University of Toledo, college of Medicine and Life Sciences supported this work. The retroviral expression vector for B-RafV600E-ERT2 is a generous gift of Dr. Martin McMahon of Huntsman Cancer Institute. UT Foundation, a gift from Clement Lam to KCY, and a Translation Research Stimulation Award (TRSA) from UT college of Medicine supported this work.
Publisher Copyright:
© 2019 Datar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2019/4
Y1 - 2019/4
N2 - Recent high-throughput-sequencing of cancer genomes has identified oncogenic mutations in the B-Raf genetic locus as one of the critical events in melanomagenesis. B-Raf encodes a serine/threonine kinase that regulates the MAPK/ERK kinase (MEK) and extracellular signal-regulated kinase (ERK) protein kinase cascade. In normal cells, the activity of B-Raf is tightly regulated and is required for cell growth and survival. B-Raf gain-of-function mutations in melanoma frequently lead to unrestrained growth, enhanced cell invasion and increased viability of cancer cells. Although it is clear that the invasive phenotypes of B-Raf mutated melanoma cells are stringently dependent on B-Raf-MEK-ERK activation, the downstream effector targets that are required for oncogenic B-Raf-mediated melanomagenesis are not well defined. miRNAs have regulatory functions towards the expression of genes that are important in carcinogenesis. We observed that miR-10b expression correlates with the presence of the oncogenic B-Raf (B-Raf V600E ) mutation in melanoma cells. While expression of miR-10b enhances anchorage-independent growth of B-Raf wild-type melanoma cells, miR-10b silencing decreases B-Raf V600E cancer cell invasion in vitro. Importantly, the expression of miR-10b is required for B-Raf V600E -mediated anchorage independent growth and invasion of melanoma cells in vitro. Taken together our results suggest that miR-10b is an important mediator of oncogenic B-Raf V600E activity in melanoma.
AB - Recent high-throughput-sequencing of cancer genomes has identified oncogenic mutations in the B-Raf genetic locus as one of the critical events in melanomagenesis. B-Raf encodes a serine/threonine kinase that regulates the MAPK/ERK kinase (MEK) and extracellular signal-regulated kinase (ERK) protein kinase cascade. In normal cells, the activity of B-Raf is tightly regulated and is required for cell growth and survival. B-Raf gain-of-function mutations in melanoma frequently lead to unrestrained growth, enhanced cell invasion and increased viability of cancer cells. Although it is clear that the invasive phenotypes of B-Raf mutated melanoma cells are stringently dependent on B-Raf-MEK-ERK activation, the downstream effector targets that are required for oncogenic B-Raf-mediated melanomagenesis are not well defined. miRNAs have regulatory functions towards the expression of genes that are important in carcinogenesis. We observed that miR-10b expression correlates with the presence of the oncogenic B-Raf (B-Raf V600E ) mutation in melanoma cells. While expression of miR-10b enhances anchorage-independent growth of B-Raf wild-type melanoma cells, miR-10b silencing decreases B-Raf V600E cancer cell invasion in vitro. Importantly, the expression of miR-10b is required for B-Raf V600E -mediated anchorage independent growth and invasion of melanoma cells in vitro. Taken together our results suggest that miR-10b is an important mediator of oncogenic B-Raf V600E activity in melanoma.
UR - http://www.scopus.com/inward/record.url?scp=85064448544&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0204387
DO - 10.1371/journal.pone.0204387
M3 - Article
C2 - 30995246
AN - SCOPUS:85064448544
SN - 1932-6203
VL - 14
JO - PLoS One
JF - PLoS One
IS - 4
M1 - e0204387
ER -